atorvastatin 10 mg film-coated tablets
dexcel pharma gmbh - atorvastatin calcium trihydrate - film-coated tablet - 10 milligram(s) - hmg coa reductase inhibitors; atorvastatin
atorvastatin 20 mg film-coated tablets
dexcel pharma gmbh - atorvastatin calcium trihydrate - film-coated tablet - 20 milligram(s) - hmg coa reductase inhibitors; atorvastatin
atorvastatin 40 mg film-coated tablets
dexcel pharma gmbh - atorvastatin calcium trihydrate - film-coated tablet - 40 milligram(s) - hmg coa reductase inhibitors; atorvastatin
deximune 25 mg soft capsules
dexcel pharma gmbh carl-zeiss-straße 2 63755 alzenau, germany - ciclosporin - soft capsule - ciclosporin 25 mg - immunosuppressants
deximune 50 mg soft capsules
dexcel pharma gmbh carl-zeiss-straße 2 63755 alzenau, germany - ciclosporin - soft capsule - ciclosporin 50 mg - immunosuppressants
deximune 100 mg soft capsules
dexcel pharma gmbh carl-zeiss-straße 2 63755 alzenau, germany - ciclosporin - soft capsule - ciclosporin 100 mg - immunosuppressants
isomel sr
dexcel pharma gmbh - isosorbid-5-mononitrat - prolonged-release tablet - 60 milligram(s) - organic nitrates; isosorbide mononitrate
amlodipin (besilat) dexcel 10 mg tablets
dexcel pharma gmbh carl-zeiss-straße 2 63755 alzenau, germany - tablet - amlodipine 10 mg - calcium channel blockers
valsartan dexcel 40
dexcel pharma technologies ltd - valsartan - film coated tablets - valsartan 40 mg - valsartan - valsartan - valsartan is indicated for the treatment of heart failure (nyha class ii-iv) in patients who are intolerant of angiotensin converting enzyme inhibitors. in a controlled clinical trial valsartan significantly reduced hospitalisations for heart failure. there is no evidence that valsartan provides added benefits when it is used with an adequate dose of an ace inhibitor. valsartan is indicated to improve survival following myocardial infarction in clinically stable patients with signs symptoms or radiological evidence of left ventricular failure and /or with left ventricular systolic dysfunction.
valsartan dexcel 80
dexcel pharma technologies ltd - valsartan - film coated tablets - valsartan 80 mg - valsartan - valsartan - valsartan is indicated for the treatment of heart failure (nyha class ii-iv) in patients who are intolerant of angiotensin converting enzyme inhibitors. in a controlled clinical trial valsartan significantly reduced hospitalisations for heart failure. there is no evidence that valsartan provides added benefits when it is used with an adequate dose of an ace inhibitor. valsartan is indicated to improve survival following myocardial infarction in clinically stable patients with signs symptoms or radiological evidence of left ventricular failure and /or with left ventricular systolic dysfunction.for treatment of hypertension.